AI for Drug Discovery Open Innovation Forum

Overview: Safe and responsible AI needs to be developed in the open. The objective of this forum is to establish a world-class open research community to drive the development, evaluation, and large-scale adoption of AI foundation models for accelerated scientific advancements for drug discovery.

The one-day event will consist of an opening session with keynotes and panels highlighting the state of the art in AI technologies and pressing bottlenecks and challenges in drug discovery, followed by breakout sessions to identify and prioritize key AI technologies and activities that should be developed in the open. The event will also include, a hands-on sessions with opportunities to work with open-source foundation models for drug discovery such as Biomedical Foundation Models. The forum will serve as the kickoff event of a new AI for Drug Discovery working group within the AI Alliance. A key objective of the forum is to identify open development priorities for this working group. This event is open to everyone—we encourage anyone interested to join us and participate.

Keynote speakers:

Joseph Loscalzo, MD, PhD, Samuel A. Levine Professor of Medicine, Hersey Distinguished Professor of the Theory and Practice of Medicine, Harvard Medical School, Physician-in-Chief Emeritus, Brigham and Women’s Hospital

Jeremy Jenkins, PhD, US Head Discovery Sciences, Novartis

Mona Singh, PhD, Wang Family Professor in Computer Science, Princeton University

Sean Mooney, PhD, Director, Center for Information Technology, NIH

This event is organized & cosponsored by Boston University’s Hariri Institute, BU Bioengineering Technology & Entrepreneurship Center, MOC Alliance, Red Hat, IBM, the Cleveland Clinic and the AI Alliance. Founded in 2023, The AI Alliance is an international community of technology developers, researchers and industry leaders who collaborate to advance safe, responsible AI rooted in open innovation.